InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 152958

Thursday, 08/21/2014 1:54:03 PM

Thursday, August 21, 2014 1:54:03 PM

Post# of 345783

Selling into this. Suspect will buy back next sale. Peace



Carboat, I disagreed with you back then in late Dec 2013 about selling and buying back because I noticed each and every time your posts "spike" up, some type of good news comes our way. Back in late Dec 2013 when you had a big spike in posts.... this news out released in early January 2014

Peregrine Pharmaceuticals Receives FDA Fast Track Designation for Its Immunotherapy Bavituximab as a Potential Treatment of Second-Line Non-Small Cell Lung Cancer

Jan 6, 2014

http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=817072



..... Now, again... I noticed a big spike in your posts and I can only hope it means we have some news that will be allowed to be told.

Good luck to all! : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News